Cargando…
MiR-95-3p acts as a prognostic marker and promotes cervical cancer progression by targeting VCAM1
BACKGROUND: Cervical cancer patients have a high risk of metastasis and a poor prognosis with shorter disease-free survival. Thus, novel biomarkers and feasible therapies urgently need to be discovered. Previous studies have shown that miR-95-3p plays crucial roles in several cancer types. However,...
Autores principales: | Feng, Sijie, Lu, Yunkun, Sun, Lisha, Hao, Shuangying, Liu, Zhiqiang, Yang, Fangyuan, Zhang, Lin, Wang, Ting, Jiang, Lihong, Zhang, Juan, Liu, Shuyan, Pang, Hui, Wang, Zhenhui, Wang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708496/ https://www.ncbi.nlm.nih.gov/pubmed/36467343 http://dx.doi.org/10.21037/atm-22-5184 |
Ejemplares similares
-
CEP20 promotes invasion and metastasis of non-small cell lung cancer cells by depolymerizing microtubules
por: Feng, Sijie, et al.
Publicado: (2023) -
VCAM1 acts in parallel with CD69 and is required for the initiation of oligodendrocyte myelination
por: Miyamoto, Yuki, et al.
Publicado: (2016) -
Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma
por: Niu, Junjie, et al.
Publicado: (2016) -
Aortic VCAM‐1: an early marker of vascular inflammation in collagen‐induced arthritis
por: Denys, Anne, et al.
Publicado: (2016) -
VCAM-1 and ICAM-1 Serum Levels as Markers of Relapse in Visceral Leishmaniasis
por: Makis, Alexandros, et al.
Publicado: (2017)